Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?
Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; PetroChina Company Limited (PTR - Free Report) .
PetroChina in Focus
PTR may be an interesting play thanks to its forward PE of 10.4 its P/S ratio of 0.4, and its decent dividend yield of 2.2%. These factors suggest that PetroChina is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that PTR has decent revenue metrics to back up its earnings.
PetroChina Company Limited PS Ratio (TTM)
But before you think that PetroChina is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 1.6% in the past 30 days, thanks to one upward revision in the past month compared to none lower.
This estimate strength is actually enough to push PTR to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So really, PetroChina is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>